Yonghe Medical Group Past Earnings Performance
Past criteria checks 0/6
Yonghe Medical Group's earnings have been declining at an average annual rate of -66.8%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 4.6% per year.
Key information
-66.8%
Earnings growth rate
-64.6%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 4.6% |
| Return on equity | -58.0% |
| Net Margin | -30.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks
Mar 31
Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?
Oct 19The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically
Sep 08Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value
Aug 19Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture
Mar 31Revenue & Expenses BreakdownBeta
How Yonghe Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,777 | -538 | 1,419 | 29 |
| 30 Sep 23 | 1,635 | -430 | 1,308 | 26 |
| 30 Jun 23 | 1,492 | -322 | 1,196 | 23 |
| 31 Mar 23 | 1,453 | -203 | 1,110 | 21 |
| 31 Dec 22 | 1,413 | -84 | 1,024 | 18 |
| 30 Sep 22 | 1,638 | 6 | 1,088 | 18 |
| 30 Jun 22 | 1,863 | 95 | 1,152 | 17 |
| 31 Mar 22 | 2,016 | 107 | 1,236 | 15 |
| 31 Dec 21 | 2,169 | 118 | 1,320 | 14 |
| 30 Sep 21 | 2,129 | 121 | 1,307 | 13 |
| 30 Jun 21 | 2,090 | 125 | 1,295 | 13 |
| 31 Mar 21 | 1,864 | 136 | 1,118 | 12 |
| 31 Dec 20 | 1,638 | 147 | 942 | 12 |
| 31 Dec 19 | 1,224 | 36 | 780 | 9 |
| 31 Dec 18 | 934 | 54 | 558 | 8 |
Quality Earnings: 2279 is currently unprofitable.
Growing Profit Margin: 2279 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2279 is unprofitable, and losses have increased over the past 5 years at a rate of 66.8% per year.
Accelerating Growth: Unable to compare 2279's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2279 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).
Return on Equity
High ROE: 2279 has a negative Return on Equity (-58.02%), as it is currently unprofitable.